Price increases for functional polymers for pharmaceutical applications

12-Nov-2010 - Germany

The Pharma polymers business line, part of Evonik Röhm GmbH, a subsidiary of Evonik Industries AG, will implement price increases for its methyl methacrylate-based polymers for pharmaceutical applications by up to 12% for their global EUDRAGIT® business, effective January 1, 2011.

The company’s priority is to enhance the quality and availability of supply and services. In this context significant investments were made to improve reliability, and to satisfy more stringent regulatory requirements. Additionally, increased wages and raw material costs are already above pre 2009 levels.

These investments will further improve the company’s infrastructure, strengthen business continuity and create competitive advantages for its pharmaceutical customers.

Other news from the department price development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances